Reference
- Edsmyr F., Huber W., Menander K. B. Orgotein efficacy in ameliorating side effects due to radiation therapy. I. Double-blind, placebo-controlled trial in patients with bladder tumors. Curr. ther. Res. 1976; 19: 198
- Huber W., Unpublished observations.
- Lund-Olesen K., Menander K. B. Orgotein. A new anti-inflammatory metalloprotein drug. Preliminary evaluation of clinical efficacy and safety in degenerative joint disease. Curr. ther. Res. 1974; 16: 706
- Marberger H., Bartsch G., Huber W., Menander K. B., Schulte T. L. Orgotein. A new drug for the treatment of radiation cystitis. Curr. ther. Res. 1975; 18: 466
- Marberger H., Huber W., Bartsch G., Schulte T., Swoboda P. Orgotein. A new anti-inflammatory metalloprotein drug. Evaluation of clinical efficacy and safety in inflammatory conditions of the urinary tract. Int. Urol. Nephrol. 1974; 6: 61
- Michelson A. M., Buckingham M. E. Effects of superoxide radicals on myoblast growth and differentiation. Biochem. biophys. Res. Commun. 1974; 58: 1079
- Oberley L. W., Lindgren A. L., Baker S. A., Stevens R. H. Superoxide ion as the cause of the oxygen effect. Radiat. Res. 1976; 68: 320
- Overgaard J., Unpublished observations.
- Petkau A., Chelack W. S. Protection of acholeplasma laidlawii B by superoxide dismutase. Int. J. radiat. Biol. 1974; 26: 421
- Petkau A., Chelack W. S., Pleskach S. D. Protection of post-irradiated mice by superoxide dismutase. Int. J. radiat. Biol. 1976; 29: 297
- Petkau A., Chelack W. S., Pleskach Meeker S. D. B. E., Brady C. M. Radioprotection of mice by superoxide dismutase. Biochem. biophys. Res. Commun. 1975; 65: 886
- Suit H. D., Shalek R. J., Wette R. Radiation response of C3H mouse mammary carcinoma evaluated in terms of cellular radiation sensitivity. Cellular radiation biology. Williams and Wilkins, Baltimore 1965; 514
- Withers H. R., Elkind M. M. Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int. J. radiat. Biol. 1970; 17: 261